Premium
A fund managed by the private equity firm OrbiMed Advisors has picked up close to 3 per cent stake in Carlyle-backed pharmaceutical company Claris Lifesciences Ltd. This is the fourth disclosed pharma investment in India by OrbiMed after Bharat Serums and Vaccines Ltd and the more recent bet on Shasun ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
